Cases 1 - 10 of 74
OWSINSKI v. AMPHASTAR PHARMACEUTICALS, INC
as 2:2023cv01340
Plaintiff:
KRISTIN I. OWSINSKI
Defendant:
AMPHASTAR PHARMACEUTICALS, INC, MYLAN INC, MYLAN LABORATORIES LIMITED and others
Cause Of Action: 28 U.S.C. § 1441 Notice of Removal-Personal Injury
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 2:2020cv13103
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, LLC
Counter Claimant:
MYLAN LABORATORIES LIMITED
Defendant:
MYLAN PHARAMACEUTICALS, INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.
as 22-1258
Plaintiff / Appellee:
JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant / Appellant:
TEVA PHARMACEUTICALS USA, INC., MYLAN LABORATORIES LIMITED and MYLAN LABORATORIES LTD.
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01395
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv01367
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00114
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv01226
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv01125
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00089
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00032
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
